← Back to Search

Low FODMAP Diet for Small Intestinal Bacterial Overgrowth

N/A
Waitlist Available
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18-65 years at the time of screening
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial found that bloating is a common symptom of IBS, which affects 11% of people worldwide. SIBO is a potential cause of bloating and is present in 78% of IBS patients. After antibiotic therapy, 48% of patients no longer had IBS. Further studies are needed to understand how FODMAPs affect intestinal permeability and microbiome.

Who is the study for?
This trial is for adults aged 18-65 who experience bloating and meet the criteria for functional bowel disorders like IBS. They must have a specific score indicating severe symptoms on an IBS symptom scale and test positive for SIBO.
What is being tested?
The study is testing whether a low FODMAP diet, which limits certain carbohydrates believed to cause discomfort, can improve symptoms in people with Small Intestinal Bacterial Overgrowth (SIBO) associated with IBS.
What are the potential side effects?
A low FODMAP diet may lead to changes in diet-related habits and could potentially result in nutritional deficiencies if not properly managed. However, it's generally considered safe with guidance from healthcare professionals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and three weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
SIBO diagnosis
Secondary study objectives
IBS-SSS
Rome IV Functional Bloating diagnostic criteria
Other study objectives
serum LPS level
serum zonulin level

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: low FODMAP dietExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
855 Previous Clinical Trials
12,930,931 Total Patients Enrolled
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top